APA (7th ed.) Citation

Kano, Y., Gebregiworgis, T., Marshall, C., Ikura, M., Miyake, S., & Ohh, M. (2021). MO14-2 KRAS Q61H mutation evades the regulation of tyrosyl phosphorylation and renders cancer cells resistant to SHP2 inhibitor. Annals of Oncology, 32, S306. https://doi.org/10.1016/j.annonc.2021.05.600

Chicago Style (17th ed.) Citation

Kano, Yoshihito, Teklab Gebregiworgis, Christopher Marshall, Mitsuhiko Ikura, Satoshi Miyake, and Michael Ohh. "MO14-2 KRAS Q61H Mutation Evades the Regulation of Tyrosyl Phosphorylation and Renders Cancer Cells Resistant to SHP2 Inhibitor." Annals of Oncology 32 (2021): S306. https://doi.org/10.1016/j.annonc.2021.05.600.

MLA (9th ed.) Citation

Kano, Yoshihito, et al. "MO14-2 KRAS Q61H Mutation Evades the Regulation of Tyrosyl Phosphorylation and Renders Cancer Cells Resistant to SHP2 Inhibitor." Annals of Oncology, vol. 32, 2021, p. S306, https://doi.org/10.1016/j.annonc.2021.05.600.